Analyst Consensus ?
ConsensusBuy12 ratings
Bullish1191.7%
Neutral18.3%
Bearish00.0%
Somnigroup International Inc · SGI · FY2026 Q1 · Calendar Q2 2026
Somnigroup grows sales and EPS as inflation and merger execution remain in focus
Somnigroup’s sales and EPS growth despite a declining bedding market supports a resilience case, while pricing elasticity, input-cost inflation, and execution of the proposed Leggett & Platt combination remain important counterweights.
Why did SGI fall 10.1% after beating EPS estimates in FY2026 Q1?
Research this report with FN2. Free to start; review your question before sending.
Reported Before market openNYSEConsumer Cyclical
$14.77B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.59
Consensus $0.57
EPS surprise
+2.8%
Reported versus consensus
Reported revenue
$1.80B
Consensus $1.83B
Revenue surprise
-1.6%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-10.1%
Event window
SPY move
-0.3%
Same window
Abnormal move
-9.8%
Stock minus SPY
Volume
2.5×
Versus trailing sessions
Subsequent drift
-3.8%
Up to 20 sessions
SGISPY benchmark
Ask FN2 about SGI FY2026 Q1
Choose a question to continue your research
Why did SGI fall 10.1% after beating EPS estimates in FY2026 Q1?What changed in SGI's guidance and outlook in FY2026 Q1?Give me the bull and bear case for SGI after FY2026 Q1 earnings.
Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Management reported first-quarter sales growth of 12% and EPS growth of 20%, described record operating cash flow and lower leverage, and announced a proposed all-stock combination with Leggett & Platt. The prior-quarter analysis had highlighted Mattress Firm synergies and the company’s raised 2026 and 2028 EPS outlook; this quarter’s analysis says full-year guidance was maintained.
Guidance delta
Management maintained full-year guidance. It expects H2 pricing actions to offset commodity inflation; the analysis says those actions are expected to be dollar-neutral to earnings. The proposed Leggett & Platt transaction remains subject to regulatory review and shareholder approval.
Key takeaways
- Sales rose 12% and EPS rose 20% year over year despite a declining bedding-industry backdrop.
- Management cited record first-quarter operating cash flow, free cash flow, and debt reduction; leverage was reported at 3.1x.
- H2 pricing actions are intended to offset commodity inflation, while a proposed Leggett & Platt combination is intended to add vertical integration and synergies.
Management priorities
- Execute new product launches and the ongoing store-refresh program.
- Use pricing actions to address input-cost inflation while maintaining earnings guidance.
- Advance the proposed Leggett & Platt combination, subject to required approvals.
Follow SGI with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$62.03Current
$80Low
$93.7Average
$106High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Nov 10, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 10, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Nov 10, 2026 |
| Stephens & Co. | Overweight | Equal Weight | Upgrade | Sep 14, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Sep 3, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 7, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 14, 2026 |
| Jefferies | Buy | Hold | Upgrade | Mar 26, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 13, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Mar 11, 2025 |
| William Blair | Outperform | Market Perform | Upgrade | Feb 5, 2025 |
| Wedbush | Outperform | Neutral | Upgrade | Feb 3, 2025 |
Named analyst price targets
Upside is calculated against the persisted current price $62.03. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Bobby Griffin | $80 | $62.8 | +29.0% | Oct 20, 2026 |
| Stephens | Jeff Lick | $80 | $66.76 | +29.0% | Sep 14, 2026 |
| Piper Sandler | Analyst unavailable | $100 | $67.82 | +61.2% | Sep 3, 2026 |
| UBS | Analyst unavailable | $102 | $67.82 | +64.4% | Sep 3, 2026 |
| Raymond James | Analyst unavailable | $90 | $64.38 | +45.1% | Aug 7, 2026 |
| UBS | Dan Silverstein | $94 | $64.49 | +51.5% | Aug 7, 2026 |
| Truist Financial | Keith Hughes | $100 | $64.87 | +61.2% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $102 | $68.43 | +64.4% | Aug 4, 2026 |
| Morgan Stanley | Pedro Gil | $95 | $71.56 | +53.2% | Jul 27, 2026 |
| UBS | Dan Silverstein | $105 | $69.1 | +69.3% | May 8, 2026 |
| Raymond James | Analyst unavailable | $95 | $69.92 | +53.2% | May 8, 2026 |
| UBS | Analyst unavailable | $110 | $75.76 | +77.3% | Apr 30, 2026 |
| Wolfe Research | Analyst unavailable | $106 | $83.16 | +70.9% | Mar 5, 2026 |
| UBS | Analyst unavailable | $115 | $87.78 | +85.4% | Feb 18, 2026 |
| Jefferies | Analyst unavailable | $90 | $87.78 | +45.1% | Feb 17, 2026 |
| UBS | Dan Silverstein | $122 | $93.74 | +96.7% | Feb 12, 2026 |
| Piper Sandler | Analyst unavailable | $70 | $54.94 | +12.8% | Mar 13, 2025 |
Track every rating change on SGI the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationSomnigroup International Inc., operating as Somni, leads the field in advanced sleep technology and holistic wellness solutions. They engineer groundbreaking products specifically designed to elevate sleep quality. Their approach seamlessly integrates scientifically validated methods, intelligent technology, and data-driven insights to optimize sleep patterns and foster overall well-being.
Historical context
All SGI earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ONON On Holding AG | FY2026 Q3 · Calendar Q4 2026 | +39.9% | -7.5% | On Holding pairs record Q3 performance with execution demands |
| SE Sea Limited | FY2026 Q3 · Calendar Q4 2026 | -5.1% | -1.5% | Sea Q3: Revenue and EBITDA Grow as Shopee Momentum Moderates |
| DKNG DraftKings Inc. | FY2026 Q3 · Calendar Q4 2026 | -29.2% | -23.4% | DraftKings Q3 growth meets lower FY2026 revenue outlook |
Latest beats and misses
Who reports nextBeat on EPS
- VGFY2026 Q3 · November 10, 2026+92.7% EPS+1.7% move
- TDGFY2026 Q4 · November 10, 2026+1.9% EPS+0.5% move
- ONONFY2026 Q3 · November 10, 2026+39.9% EPS-7.5% move
- CRWVFY2026 Q3 · November 10, 20260.0% EPS-0.5% move
- OXYFY2026 Q3 · November 9, 2026+30.8% EPS+2.0% move
- MGREFY2026 Q3 · November 9, 2026+8.1% EPS+0.6% move
Missed on EPS
- EMBJFY2026 Q3 · November 10, 2026-49.4% EPS+7.0% move
- VODFY2027 Q2 · November 10, 2026-72.8% EPS-1.2% move
- SEFY2026 Q3 · November 10, 2026-5.1% EPS-1.5% move
- BAPFY2026 Q3 · November 9, 2026-2.6% EPS+3.3% move
- JBSFY2026 Q3 · November 9, 2026-28.6% EPS-5.5% move
- CIBFY2026 Q3 · November 9, 2026-10.1% EPS-4.0% move
Get the SGI recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-11-10T00:40:42.538022+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-10T00:40:42.535134+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-10. For educational purposes only; not investment advice.